Copolymerized PEGlyated Acrylate Hydrogels for Delivery of Dicolofenac Sodium - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Copolymerized PEGlyated Acrylate Hydrogels for Delivery of Dicolofenac Sodium
Hydrogels are biocompatible drug delivery systems by which the physical properties can be controlled by the cross-linking density. Hydrogels were prepared by copolymerization of acrylic acid monomers in the presence of poly(ethylene glycol)(PEG) to form polyethylene diacrylate (PEDGA). Various molecular weights of PEGs were used for the synthesis of PEGDA to study the effect of molecular weight of PEG on the properties of hydrogels. These hydrogels were further characterized for free water, swelling..


Pharmaceutical Technology


8. N.A. Peppas et al., "Hydrogels in Pharmaceutical Formulations," Eur. J. Pharm. Biopharm. 50 (1), 27–46 (2000).

9. V.R. Patel and M.M. Amiji, "Preparation and Characterization of Freeze-Dried Chitosan Poly(ethylene oxide) Hydrogels for Site-Specific Antibiotic Delivery in the Stomach," Pharm. Res. 13 (44), 588–593 (1996).

10. V.R. Sinha and L. Khosla, "Bioabsorbable Polymers for Implantable Therapeutic Systems." Drug Dev. Ind. Pharm. 24 (12), 1129–1138 (1998).

11. J.Y. Fang et al., "Transdermal Iontophoresis of Sodium Nonivamide Acetate IV Effect of Polymer Formulations," Int. J. Pharm.173 (1–2), 127–140 (1998).

12. J.Y. Fang et al.,"Evaluation of Transdermal Iontophoresis of Enoxacin from Polymer Formulations: In Vitro Permeation and In vivo Microdialysis Using Wister Rat as an Animal Model," Int. J. Pharm. 180 (2), 137–149 (1999).

13. O.M. Conaghey, J. Currish, and O.I. Corrigan, "Iontophoretically Assisted In Vitro Membrane Transport of Nicotine from a Hydrogel Containing Ion Exchange Resins," Int. J. Pharm. 170 (2), 225–237 (1998).

14. A. Kikuchi and T. Okano, "Pulsatile Drug Release Control Using Hydrogels," Adv. Drug Del. Rev. 54 (1), 53–77 (2002).

15. T.A. Holland, Y. Tabata, and A.G. Mikos, "Dual Growth Factor Delivery from Degradable Oligo(Poly(ethylene glycol) Fumarate) Hydrogel Scaffolds for Cartilage Tissue Engineering," J. Controlled Release 101 (1–3), 111–125 (2005).

16. S.V. Vinogradov, T.K. Bronich, and A.V. Kabanov, "Nanosized Cationic Hydrogels for Drug Delivery: Preparation, Properties and Interactions with Cells," Adv. Drug Del. Rev. 54 (1), 135–147 (2002).

17. L.F. Wang, S.S. Shen, and S.C. Lu, "Synthesis and Characterization of Chondroitin Sulfate-Methacrylate Hydrogels," Carbohydrate Polymers 52 (4), 389–396 (2003).

18. G.V Mooteo, L. Vervoort, and R. Kinget, "Characterization of Methacrylated Inulin Hydrogels Designed for Colon Targeting: In Vitro Release of BSA," Pharm. Res. 20 (2), 303–307 (2003).

19. S.N. Park et al., "Biological Characterization of EDC Crosslinked Collagen-Hyaluronic Acid Matrix in Dermal Tissue Restoration," Biomaterials 24 (9), 1631–1641 (2003).

20. S. Cai et al., "Injectable Glycosaminoglycan Hydrogels for Controlled Release of Human Basic Fibroblast Growth Factor," Biomaterials 26 (30), 6054–6067 (2005).

21. X. Lou et al., "Morphological and Topographic Effects on Calcification Tendency of pHEMA Hydrogels." Biomaterials 26 (29), 5808–5817 (2005).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology,
Click here